Literature DB >> 8697044

Biological actions of drugs affecting serotonin and eating.

S Garattini1.   

Abstract

The present status of knowledge on drugs affecting food intake and presumably acting via a serotoninergic mechanism is reviewed. The mechanism of action of these drugs is analyzed at the neurochemical level. All the drugs, to various extents, inhibit the uptake of serotonin (5HT), increase the release of 5HT and decrease brain levels of 5HT and 5HIAA. However, the underlying mechanisms are not identical as exemplified by comparisons made with d-fenfluramine, d-norfenfluramine, fluoxetine, sertraline and paroxetine. An analysis of the role of 5HT in the inhibition of food intake reveals that only d-fenfluramine is inhibited by antiserotonin agents. The role of the different 5HT receptor-subtypes in this antagonism is discussed. More selective 5HT antagonists are needed to establish which 5HT receptor(s) controls food intake.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8697044     DOI: 10.1002/j.1550-8528.1995.tb00213.x

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  6 in total

1.  Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis.

Authors:  G Calapai; F Corica; A Corsonello; L Sautebin; M Di Rosa; G M Campo; M Buemi; V N Mauro; A P Caputi
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

Review 2.  Molecular genetics of monoamine transporters: relevance to brain disorders.

Authors:  K Haddley; A S Vasiliou; F R Ali; U M Paredes; V J Bubb; J P Quinn
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

Review 3.  Serotonergic drugs and valvular heart disease.

Authors:  Richard B Rothman; Michael H Baumann
Journal:  Expert Opin Drug Saf       Date:  2009-05       Impact factor: 4.250

4.  Fenfluramine-induced PVAT-dependent contraction depends on norepinephrine and not serotonin.

Authors:  Ramya K Kumar; Emma S Darios; Robert Burnett; Janice M Thompson; Stephanie W Watts
Journal:  Pharmacol Res       Date:  2018-09-03       Impact factor: 7.658

5.  Pharmacological management of binge eating disorder: current and emerging treatment options.

Authors:  Susan L McElroy; Anna I Guerdjikova; Nicole Mori; Anne M O'Melia
Journal:  Ther Clin Risk Manag       Date:  2012-05-08       Impact factor: 2.423

Review 6.  Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases.

Authors:  Giuseppe Di Giovanni; Dubravka Svob Strac; Montse Sole; Mercedes Unzeta; Keith F Tipton; Dorotea Mück-Šeler; Irene Bolea; Laura Della Corte; Matea Nikolac Perkovic; Nela Pivac; Ilse J Smolders; Anna Stasiak; Wieslawa A Fogel; Philippe De Deurwaerdère
Journal:  Front Neurosci       Date:  2016-11-24       Impact factor: 4.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.